The division has been set up with the aim to evaluate existing and upcoming market opportunities for the burgeoning Indian healthcare industry. It provides market research and feedback, supports with its vast experience in import registration, successful commercialization of products and post launch market feedback. This division already registered more than 50 products.

Our regulatory experience has also helped us in successfully completing clinical trials and registration of following formulations:

1.       Inactivated Influenza Vaccine (Split Virion) IP

2.       Botullinum toxinType A

3.       GCSF Pre-filled syringes